Compare Hims and Hers Health Inc (HIMS) vs Sony Group Corp (SONY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Sony Group Corp — how do they compare? Hims and Hers Health Inc trades at $32.43 (market cap $7.57B), while Sony Group Corp trades at $21.13 (market cap $125.96B). The key difference: Sony Group Corp is far larger — about 16.6× Hims and Hers Health Inc's market cap, and Sony Group Corp pays a 0.75% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.
| HIMS | SONY | |
|---|---|---|
Market Cap | $7.57B | $125.96B |
Sector | Health | Technology |
52-Week High | $66.18 | $30.26 |
52-Week Low | $14.52 | $19.32 |
Enterprise Value | $7.95B | $122.45B |
Dividend Yield | — | 0.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.
The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.
Sony trades at $21.165 with modest daily gains of 0.21%, supported by strong technical momentum and bullish analyst sentiment. The company demonstrates solid fundamentals with $12.96T in revenue and $1.14T net income for 2025, though recent Q1 2026 earnings missed expectations. Sony's entertainment strategy expansion and digital gaming transition position it for long-term growth despite near-term execution risks.
Sony presents a compelling investment case with strong cash flow generation and analyst support, though investors must monitor the digital gaming transition execution and potential revenue volatility. The stock's current valuation metrics appear reasonable given the company's market position and growth initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Sony Group Corp
Sony Group is a conglomerate with consumer electronics roots, which not only designs, develops, produces, and sells electronic equipment and devices, but also is engaged in content businesses, such as console and mobile games, music, and movies. Sony is a global top company of CMOS image sensors, game consoles, professional broadcasting cameras, and music publishing, and is one of the top players on digital cameras, wireless earphones, recorded music, movies, and so on. Sony's business portfolio is well diversified with six major business segments. The company fully consolidated Sony Financial in September 2020, which provides life and non-life insurance, banking, and other financial services.
Read more on SONY →
